tiprankstipranks
Evaxion Biotech (EVAX)
NASDAQ:EVAX
US Market

Evaxion Biotech (EVAX) Financial Statements

Compare
326 Followers

Evaxion Biotech Financial Overview

Evaxion Biotech's market cap is currently $3.12M. The company's EPS TTM is $-14.543; its P/E ratio is ―; Evaxion Biotech is scheduled to report earnings on April 8, 2025, and the estimated EPS forecast is $-2.02. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue$ 73.00K$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 72.89K$ -571.32K$ -343.45K$ -105.72K$ -80.98K
Operating Income$ -22.20M$ -25.26M$ -25.83M$ -16.57M$ -10.86M
EBITDA$ -21.40M$ -22.58M$ -24.17M$ -16.46M$ -11.90M
Net Income$ -22.13M$ -23.17M$ -24.53M$ -15.02M$ -11.20M
Balance Sheet
Cash & Short-Term Investments$ 5.58M$ 13.18M$ 32.17M$ 5.83M$ 9.56M
Total Assets$ 12.89M$ -58.94M$ 40.16M$ 11.96M$ 11.08M
Total Debt$ 10.87M$ 2.25M$ 3.69M$ 20.00K$ 36.00K
Net Debt$ 5.29M$ -10.93M$ -28.48M$ -5.81M$ -9.52M
Total Liabilities$ 17.62M$ 13.72M$ 7.73M$ 4.93M$ 1.72M
Stockholders' Equity$ -4.73M$ -72.66M$ -50.43M$ 7.04M$ 9.36M
Cash Flow
Free Cash Flow$ -17.78M$ -26.07M$ -23.29M$ -12.83M$ -7.09M
Operating Cash Flow$ -17.69M$ -25.77M$ -21.93M$ -12.44M$ -7.03M
Investing Cash Flow$ -93.00K$ -268.00K$ -1.33M$ -393.00K$ -61.00K
Financing Cash Flow$ 10.69M$ 7.85M$ 49.80M$ 8.82M$ 9.51M
Currency in USD

Evaxion Biotech Earnings and Revenue History

Evaxion Biotech Debt to Assets

Evaxion Biotech Cash Flow

Evaxion Biotech Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis